{
    "medicine_id": "9aa3f92ecf5c16a939f05703ec8a0f82dd4770a1",
    "platform_id": "DB05801",
    "metadata": {
        "name": "Kadcyla 160 mg Powder for solution",
        "composition": "160 mg GTI 2040",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in breast cancer colorectal cancer leukemia myeloid leukemia unspecified myelodysplastic syndrome prostate cancer renal cell carcinoma and solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}